Below is a brief explanation about how to AEVOLVE biosphere brings together “payers”, financing, and medical service providers into one ecosystem to support breakthrough innovations.
Biospheres are created through a stringent selection process, wherein partnered NGO and advocacy groups identify medical service providers (MSPs) identify and present these opportunities to AVEX! token holders for community voting.
Once selected, the treatment is carefully examined and scrutinized by a world-class team of scientific curators paid in AVEX! tokens from the treasury to consistently review new projects on their merit and support commercialization planning. Upon approval of the project by the scientific curators the Biosphere will be generated along with its unique ERC-20 sphere voucher NFT. It now becomes open for staking AVEX! tokens to support a Biosphere project.
An example to better the real utility of the project. Let us take the devastating progressive neurodegenerative disease, ALS. The ALS Association identifies a range of compelling projects lacking the necessary funding to complete required regulatory clearance. They can bring these projects to the AEVOLVE ecosystem for community voting. The projects with enough support are moved to the scientific curators for diligence.
The team is comprised of a multi-disciplinary team of experts that will review the business, regulatory, technical, and clinical challenges to weigh the viability of each project. So let’s say we start with 20 initial projects for community voting of which 8 enter diligence upon which only 3 are viable. Each project will have its associated biosphere and unique ERC-20 token.
AVEX! tokens are purchased from a cryptocurrency exchange and staked in a biosphere; the owner of the staked tokens earns a Sphere Voucher displayed as an NFT in the wallet which staked the AVEX! tokens initially.
Continuing the ALS example, if you discover the biosphere related to an innovative ALS treatment you’d like to support in a low-risk manner through staking and potential share in the upside of selling or donating a Sphere voucher for treatment. It is as easy as buying AVEX! tokens from an exchange and then just staking it to the ALS treatment biosphere.
AEVOLVE has worked tirelessly to converge cryptocurrency and traditional financial markets. This has been achieved through the introduction of an innovative Swiss ISIN financial instrument collateralized against bank vaulted AVEX! tokens. This makes it possible now for non-crypto currency investors to participate in the AEVOLVE ecosystem as well as leverage more complex financial methods to de-risk and capitalize the ecosystem.
Once a biosphere reaches its staking threshold (aka. Fundraising goal) and MSP complies with the required diligence, the AVEX! foundation will secure the most opportune financing option against the staked biosphere pool to leverage the locked liquidity without taking funds out of the AVEX! liquidity. An initial tranche of funding will be made available to MSP and released as defined by the milestones created at the Biosphere’s inception.
Once the ALS biosphere has reached it is funding threshold, for example, USD 2,500,000 then the AEVOLVE foundation will secure financing based on the staking pool leveraging the AVEX! tokens integration with traditional financial markets to both provide either the MSP funding directly or managed through a trusted NGO to distribute the funding. Of the funding, only a portion will be released to the MSP initially to mitigate project failure risks and released as milestones are met. This will allow MSPs to secure friendly financing term to do crucial work during the most difficult phase of medical innovation commercialization to both secure additional sources of funding and showcase market demand.
Upon the commercial release of the MSPs product, the biosphere project will close. Upon closing holders will be returned their staked AVEX! reward as well as get reward Sphere vouchers proportional to the staked AVEX!. All information about each voucher is stored securely on the voucher itself since it is minted as an NFT. Once presented to the MSP, the treatment is given out to the one who submits the voucher for redemption. Ownership of vouchers is transferable or exchanged for sale in the AEVOLVE Ecosystem often at a premium.
Once the ALS treatment is released to the market, the biosphere project will be shut. This will trigger the un-staking of AVEX! tokens, the release of Sphere Voucher, and the funding release to MSP. Sphere voucher NFT holders can redeem their treatment based on the terms found within the agreement stored in the NFT. The Medical Service Provider will be liable to fulfill the vouchers. For example, benefits of the Sphere vouchers can include securing an earlier spot in the treatment queue, discounted costs, or preferred services.
Sphere Voucher holders can donate ownership through an NFT transfer to the identified NGO or an individual, else they can sell it within the AEVOLVE marketplace to realize financial gains from supporting the commercialization of revolutionary medical innovations.